z-logo
open-access-imgOpen Access
Placental Implications of Peroxisome Proliferator-Activated Receptors in Gestation and Parturition
Author(s) -
Valérie Borel,
Denis Gallot,
Geoffroy Marceau,
Vincent Sapin,
Loı̈c Blanchon
Publication year - 2008
Publication title -
ppar research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.164
H-Index - 49
eISSN - 1687-4765
pISSN - 1687-4757
DOI - 10.1155/2008/758562
Subject(s) - placenta , placentation , biology , cytotrophoblast , peroxisome proliferator activated receptor , gestation , chorioamnionitis , receptor , endocrinology , medicine , fetus , pregnancy , biochemistry , genetics
The placenta is a transitory structure indispensable for the proper development of the embryo and fetus during mammalian gestation. Like other members of the nuclear receptor family, the peroxisome proliferator-activated receptors (PPARs) are known to be involved in the physiological and pathological events occurring during the placentation. This placental involvement has been recently reviewed focusing on the early stages of placental development (implantation and invasion, etc.), mouse PPARs knockout phenotypes, and cytotrophoblast physiology. In this review, we describe the placental involvement of PPARs (e.g., fat transport and metabolism, etc.) during the late stages of gestation and in the amniotic membranes, highlighting their roles in the inflammation process (e.g., chorioamnionitis), metabolic disorders (e.g., diabetes), and parturition.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom